###### Key messages

-   How is the consensus among expert clinicians and patients about the inclusion of individual care items into a discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease (COPD)?

-   Seven evidence-based care items were included in a COPD discharge bundle based on clinician and patient input.

-   This is the first use and reporting of a modified Delphi method to develop a COPD discharge care bundle informed by evidence, multidisciplinary clinical consensus and patients' perspectives.

Introduction {#s1}
============

Chronic obstructive pulmonary disease (COPD) is a common, chronic lung disease characterised by progressive and not fully reversible airflow limitation. Acute exacerbations of COPD are defined by worsening in patients' baseline symptoms of dyspnoea, cough and sputum (quantity and purulence); exacerbations become more frequent and severe as the disease progresses.[@R1] These events constitute the single most important determinant of health status in patients with COPD[@R2] and account for increased morbidity, frequent emergency department (ED) visits, hospitalisations and death.[@R3]

A cornerstone of COPD management is preventing acute exacerbations of COPD and breaking the cycle of recurrence. A large body of evidence supports both pharmacological and non-pharmacological interventions to reduce the risk of acute exacerbations of COPD and improve overall health status.[@R5] Despite this evidence, important care gaps remain as patients are often discharged from hospital or the ED following an acute exacerbation of COPD with no clear plan to prevent future episodes.[@R6] Information exchange between hospital, ED and primary care physicians about the acute exacerbation of COPD is often incomplete or unavailable at the first postdischarge outpatient appointment.[@R7] Often, patients and families assume care coordination responsibilities and personally convey follow-up instructions to primary care physicians. Information is sometimes provided verbally, and patients often struggle with health literacy issues.[@R8] This creates a critical situation in which inaccurate information is translated from acute to community care settings. There is a need to improve transitions of care for patients with COPD across ED, hospital and community settings and ensure coordination and continuity of care.[@R10]

Care bundles aim to meet these challenges and overcome inconsistencies in clinical decision-making while supporting the translation of evidence to enhance COPD care. The Institute for Healthcare Improvement has defined care bundles as 'a structured way of improving the processes of care and patient outcomes: a small, straightforward set of evidence-based practices that, when performed collectively and reliably, have been proven to improve patient outcomes'.[@R11] A COPD discharge care bundle comprises a short list of evidence-based interventions that should be implemented prior to discharge of all patients with acute exacerbations of COPD.[@R12]

A systematic review on the effectiveness of COPD discharge care bundles[@R13] found moderate evidence that their implementation is likely to reduce readmissions after acute exacerbations of COPD. The review highlighted the importance of documenting the individual components of care bundles and understanding their interactions to influence patient outcomes. Ideally, the decision to include individual interventions in a COPD discharge bundle should be guided by best evidence, clinical expertise and patient values.[@R14] Despite the existence of clinical practice guidelines for COPD,[@R1] there is no consensus about the core COPD care items that should be implemented at discharge to ensure a smooth transition to the community and reduce the risk of relapse.[@R19] This study describes the development of a discharge care bundle for patients with COPD that is based on evidence, consensus among clinical experts and patients' feedback.

Methods {#s2}
=======

The study was conducted from July to November 2015 and consisted of a two-round, modified Delphi survey plus one face-to-face nominal group meeting.[@R20] The Delphi procedure is an explorative approach that uses a series of questionnaires to gather information about a topic of relevance to the participants in the study.[@R21] It comprises distinct characteristics: anonymity, iteration, controlled feedback and statistical group response as expression of the degree of consensus.[@R21] The aim of the process is to find consensus within a group of experts. In this study, patients were also regarded as experts for their individual experiences with accessing COPD care.

A purposeful sample of 340 clinician experts was invited to participate. They were selected based on their clinical and research experience in the evaluation and treatment of patients with COPD. The study population included health providers involved in various aspects of COPD care (ie, hospital, emergency and primary care) in Alberta (Canada), and all members of the Canadian Thoracic Society (CTS) COPD Clinical Assembly. Names of Alberta clinician experts were obtained from websites of the College of Physicians and Surgeons of Alberta, the College and Association of Respiratory Therapists of Alberta, clinical departments at the University of Alberta and University of Calgary, and Alberta Health Services, which is the single health authority for the province. A convenience sample of 34 patients with COPD was recruited from two multidisciplinary respiratory clinics in Edmonton and Calgary (Alberta) using flyers distributed during their clinical appointments and by health providers' referral. Since the aim was to recruit 'representative' patients in terms of their experiences with COPD care at hospital discharge and not a representative overall sample, no exclusion criteria by COPD severity or demographic characteristics were applied.

Clinical experts were individually contacted by email, and patients were contacted in person. Each received a letter of consent describing the study and the expectations regarding their participation. A list of 29 unique COPD care actions occurring at either hospital or ED discharge was derived from a systematic review of the literature[@R13] and clinical practice guidelines,[@R4] and included in the round 1 questionnaire. The questionnaires were pretested with a sample of two clinician experts and two patients not involved in subsequent Delphi rounds. The content of the patients' questionnaires was adapted for a grade 6 level of reading to enhance comprehensiveness and acceptance.

[Figure 1](#F1){ref-type="fig"} describes the study flow. In round 1, participants rated the importance of 29 unique COPD discharge care items on a seven-point Likert-type scale (1=extremely unimportant and 7=extremely important). In round 2, participants were presented with a list of COPD discharge items for which consensus was achieved in round 1 along with the group's ratings. Participants were asked to reflect on the group responses and rate the importance of each COPD discharge item. For all Delphi rounds, consensus about the importance of individual COPD care items was defined a priori as at least 80% of endorsement for Likert values 5--7. Both first-round and second-round questionnaires for clinicians were distributed online via Research Electronic Data Capture (Vanderbilt University; Nashville, Tennessee, USA). The round 2 questionnaire was sent to all clinicians regardless of their participation in the first round. Non-respondents were sent two reminders at 2-week intervals after the initial distribution. Patients participating in round 1 were invited to complete the round 2 questionnaire at their next follow-up clinical visit. A face-to-face, nominal group meeting was convened in Edmonton on 16 November 2015. The 44 participants included the CTS COPD Clinical Assembly, clinicians, researchers and health administrators from Alberta with experience in COPD care. Results of Delphi rounds 1 and 2 were presented to meeting participants. They were invited to add new care items and review their wording prior to voting. Using a dot-counting method,[@R24] participants selected individual care items for inclusion in the COPD discharge bundle based on the information gathered from the Delphi rounds, the systematic review,[@R13] clinical expertise and patients' feedback. The level of consensus for voting of individual COPD care items during the nominal group meeting was indicated by values above the median rank value.[@R25]

![Flow diagram of Delphi procedures and study participants. COPD, chronic obstructive pulmonary disease.](bmjresp-2017-000265f01){#F1}

Descriptive statistics were used to report consensus. The level of agreement between clinicians and patients in Delphi round 1 was calculated using κ[@R26] with 95% CIs, and classified as poor (κ\<0.00), slight (k=0--0.20), fair (κ=0.21--0.40), moderate (κ=0.41--0.60), substantial (κ=0.61--0.80) and almost perfect (κ\>0.80).[@R27] Data from Likert scales were treated as categorical data and reported as proportions with percentages. Predictive Analysis Software Statistics for Mac (PASWV.18.0, IBM SPSS, Somers, New York, USA) was used for all the analyses.

Results {#s3}
=======

Delphi participants {#s3a}
-------------------

Of 340 potentially eligible clinicians that were approached via email, 70 (20.5%) completed the first Delphi round and 73 (21.4%) participated in round 2. The expert panel that completed Delphi round 2 (see [table 1](#T1){ref-type="table"}) included medical practitioners such as pulmonologists (27.1%), internists (14.3%), family/general practitioners (11.4%), emergency physicians (7.1%), geriatricians (2.9%) and allied health providers including respiratory therapists (27.4%), physical therapists (4.1%) and primary care nurses (2.7%). Clinicians were mostly based at academic hospitals (68.1%), specialty clinics (36.2%) and the ED (23.1%). The majority of them had between 16 and 30 years of experience within their disciplines (41.2%).

###### 

Characteristics of clinician participants in Delphi study

  Variable                                  n (%)
  ----------------------------------------- --------------
  Sex                                       
    Male                                    36 (49.3)
   Female                                   35 (47.9)
   NR                                       2 (2.7)
  Age (years)                               
   \<29                                     2 (2.7)
   30--39                                   16 (21.9)
   40--49                                   20 (27.4)
   50--59                                   24 (32.9)
   \>60                                     9 (12.3)
   NR                                       2 (2.7)
  Clinical discipline                       
   Medical                                  
    Pulmonologist                           19 (27.1) \*
    Internist                               10 (14.3) \*
    Family physician/general practitioner   8 (11.4)\*
    Emergency physician                     5 (7.1)\*
    Geriatrician                            2 (2.9)\*
   Allied                                   
    Respiratory therapist                   20 (27.4)\*
    Other (not specified)                   10 (7.3) \*
    Physical therapist                      3 (4.1)\*
    Primary care nurse                      2 (2.7)\*
  Work setting                              
   Acute care hospital                      47 (68.1)\*
   Specialty clinic                         25 (36.2) \*
   Emergency department                     16 (23.1)\*
   Primary care                             11 (15.9)\*
   Other                                    11 (15.9)\*
  Location of practice                      
   Urban                                    55 (75.4)
   Semi-rural/rural                         8 (10.9)
   NR                                       10 (13.7)
  Years of practice                         
   \<15                                     26 (35.5)
   16--30                                   30 (41.2)
   \>30                                     16 (21.9)
   NR                                       1 (1.4)

\*Multiple responses were allowed.

NR, not reported.

A total of 34 patients ([table 2](#T2){ref-type="table"}) completed the round 1 questionnaire and 9 participated in round 2. Patients were mostly female (67.6%), older than 60 years of age (58.8%) and diagnosed with COPD in the last 10 years. Further, 70.6% of them had one or more admissions for acute exacerbation of COPD in the last year.

###### 

Characteristics of patient participants in Delphi study

  Variable                                     n (%)
  -------------------------------------------- -------------
  Sex (n=34)                                   
    Male                                       10 (29.4)
   Female                                      23 (67.6)
   NR                                          1 (2.9)
  Age (years)                                  
   40--49                                      3 (8.8)
   50--59                                      9 (26.5)
   ≥60                                         20 (58.8)
   NR                                          2 (5.9)
  Place of residence                           
   Urban                                       14 (41.2)
   Rural                                       12 (35.3)
   NR                                          8 (23.5)
  Time since COPD diagnosis (years)            
   \<2                                         4 (11.8)
   2-- 5                                       8 (23.5)
    6-- 10                                     9 (26.5)
   11-- 15                                     4 (11.8)
   16-- 20                                     3 (8.8)
   21-- 25                                     2 (5.9)
   NR                                          4 (11.8)
  COPD admissions last year                    
   0                                           7 (20.6)
   1                                           9 (26.5)
   2--3                                        7 (20.6)
   ≥4                                          8 (23.5)
   NR                                          3 (8.8)
  Living conditions                            
   Live independent                            15 (44.1)\*
   Live with someone that can help with care   16 (47.1)\*
   Live in rural area                          7 (20.6)\*
   Live in a small town                        6 (17.6)\*
   Live in city                                19 (55.9)\*
   Drive to appointments                       15 (44.1)\*
   Rely on others to go to appointments        7 (20.6)\*

\*Multiple responses were allowed.

COPD, chronic obstructive pulmonary disease; NR, not reported.

### Delphi results {#s3a1}

From 29 individual care items that were presented in round 1, clinicians selected 17 COPD care items, while patients endorsed 13 COPD care items ([table 3](#T3){ref-type="table"}). The level of agreement between clinicians and patients in the round 1 selection of COPD items was moderate (κ=0.46; 95% CI 0.15 to 0.76). There were some discrepancies between clinicians and patients in the prioritisation of COPD care items in round 1. The COPD care items endorsed by clinicians but not by patients were (1) assess smoking status and provide counselling, (2) refer to smoking cessation programme, (3) assess need for home care, (4) refer to pulmonary rehabilitation, (5) provide recommendations about influenza vaccination and (6) administer influenza vaccine. In contrast, two COPD care items were endorsed by patients but not by clinicians: (1) provide written education about COPD, a written action plan and ongoing case management, and (2) arrange follow-up appointment with a specialist.

###### 

Delphi round 1 endorsement (%) of clinicians and patients on individual care items for inclusion in the chronic obstructive pulmonary disease (COPD) discharge bundle

  Individual COPD care bundle items                                                                                                         Clinicians      Patients
  ----------------------------------------------------------------------------------------------------------------------------------------- --------------- ---------------
  1\. Ensure adequate inhaler technique is demonstrated                                                                                     71 (**98.5**)   33 (**91**)
  2\. Assess patient comprehension of discharge instructions                                                                                73 (**97.2**)   34 (**97**)
  3\. Assess need for oxygen therapy (short-term or long-term domiciliary oxygen)                                                           73 (**97.2**)   33 (**84.8**)
  4\. Reconcile full range of respiratory medications                                                                                       72 (**95.9**)   34 (**88.2**)
  5\. Arrange follow-up appointment with family physician. If patient does not have one, have him/her connected with one before discharge   73 (**94.5**)    3 (**84.4**)
  6\. Prescribe maintenance respiratory medications                                                                                         72 (**94.5**)   33 **(100)**
  7\. Review full range of respiratory medications                                                                                          72 (**94.5**)   34 (**88.1**)
  8\. Assess smoking status and provide counselling, as needed                                                                              72 (**94.5**)   34 (73.6)
  9\. Send discharge summary to family physician                                                                                            71 (**94.3**)   34 (**88.2**)
  10\. Refer to smoking cessation programme, as needed                                                                                      72 (**91.7**)   32 (78.1)
  11\. Assess need for home care                                                                                                            72 (**91.7**)   32 (65.6)
  12\. Refer to pulmonary rehabilitation, as needed                                                                                         73 (**90.5**)   34 (79.4)
  13\. Provide recommendations about influenza vaccination                                                                                  72 (**90.3**)   32 (75)
  14\. Provide recommendations about pneumococcal vaccination                                                                               72 (**90.2**)   32 (**81.2**)
  15\. Provide a written discharge action plan (a subacute plan of monitoring/management to prevent COPD relapse)                           72 (**86.1**)   32 (**81.3**)
  16\. Administer pneumococcal vaccine, as needed                                                                                           72 (**84.8**)   33 (**81.9**)
  17\. Administer influenza vaccine, as needed.                                                                                             72 (**83.3**)   33 (75.8)
  18\. Provide a written COPD action plan (a chronic care plan of monitoring/management to prevent COPD relapse)                            73 (78.1)       32 (78.1)
  19\. Provide written education about COPD + written  action plan + ongoing  case management                                               70 (75.7)       34 (**82.4**)
  20\. Assess need for occupational therapy referral                                                                                        70 (75.7)       32 (78.2)
  21\. Arrange follow-up appointment with a respiratory nurse or certified respiratory educator                                             72 (75.1)       33 (69.7)
  22\. Assess need for social work referral                                                                                                 72 (72.2)       32 (56.3)
  23\. Provide written education about COPD + a  written action plan                                                                        73 (71.2)       34 (70.5)
  24\. Assess need for nutrition services referral                                                                                          73 (71.2)       32 (71.9)
  25\. Follow-up phone calls after discharge                                                                                                73 (67.1)       33 (66.6)
  26\. Arrange follow-up appointment with a specialist                                                                                      72 (66.7)       33 (**84.9**)
  27\. Arrange for lung function testing after discharge                                                                                    72 (66.7)       33 (69.7
  28\. Provide written education about COPD management                                                                                      72 (66.7)       34 (73.6)
  29\. Perform spirometry at discharge                                                                                                      72 (54.2)       32 (62.5)

Endorsement≥80% indicated in bold.

N, the total number of respondents per individual item.

In round 2, clinicians were presented with the 17 COPD care items that were selected in round 1 and retained 15 of them. Patients in round 2 were presented with the 13 COPD care items selected from round 1, of which they retained 9 ([table 4](#T4){ref-type="table"}). There were discrepancies between clinicians and patients in their round 2 decisions: three COPD care items were endorsed by clinicians but not by patients: (1) ensure adequate inhaler technique is demonstrated, (2) arrange follow-up appointment with family physician and (3) assess need for oxygen therapy. Care items selected by patients but not by clinicians at the end of round 2 were the same as those in round 1.

###### 

Delphi round 2 endorsement of clinicians and patients on individual care items for inclusion in the chronic obstructive pulmonary disease (COPD) discharge bundle

  Individual COPD care bundle items                                                                                                         Clinicians      Patients
  ----------------------------------------------------------------------------------------------------------------------------------------- --------------- --------------
  1\. Ensure adequate inhaler technique is demonstrated                                                                                     73 (**98.6**)   9 (77.7)
  2\. Send discharge summary to family physician                                                                                            73 (**98.6**)   9 (**88.9**)
  3\. Reconcile full range of respiratory medications                                                                                       73 (**98.6**)   9 (**100**)
  4\. Assess patient comprehension of discharge instructions                                                                                73 (**97.3**)   9 (**100**)
  5\. Review full range of respiratory medications                                                                                          72 (**97.2**)   9 (**100**)
  6\. Arrange follow-up appointment with family physician. If patient does not have one, have him/her connected with one before discharge   73 (**95.8**)   9 (66.6)
  7\. Prescribe maintenance respiratory medications                                                                                         72 (**94.5**)   8 (**88.9**)
  8\. Assess need for oxygen therapy (short-term or long-term domiciliary oxygen)                                                           72 (**94.4**)   9 (77.8)
  9\. Assess smoking status and provide counselling, as needed                                                                              73 (**91.7**)   ns
  10\. Assess need for home care                                                                                                            71 (**91.6**)   ns
  11\. Refer to smoking cessation programme, as needed                                                                                      71 (**88.7**)   ns
  12\. Refer to pulmonary rehabilitation, as needed                                                                                         72 (**86.2**)   ns
  13\. Provide recommendations about influenza vaccination                                                                                  72 (**84.7**)   ns
  14\. Provide recommendations about pneumococcal vaccination                                                                               73 (**82.2**)   9 (**88.8**)
  15\. Provide a written discharge action plan (a subacute plan of monitoring/management to prevent COPD relapse)                           72 (**80.5**)   9 (**88.8**)
  16\. Administer influenza vaccine, as needed                                                                                              73 (78)         ns
  17\. Administer pneumococcal vaccine, as needed                                                                                           71 (71.8)       9 (66.6)
  18\. Arrange follow-up appointment with a specialist                                                                                      ns              9 (**88.9**)
  19\. Provide written education about COPD + written  action plan + ongoing  case management                                               nsns            9 (**88.8**)

Endorsement≥80% indicated in bold.

N, the total number of respondents per individual item; ns, not selected for round 2.

Nominal group meeting: participants and results {#s3b}
-----------------------------------------------

Participants in the nominal group meeting (n=44) were members of the CTS COPD Assembly (n=9), pulmonologists (n=8), researchers (n=7), health administrators (n=7), respiratory therapists (n=5), primary care physicians (n=5), emergency physicians (n=2) and geriatricians (n=1). They were presented with 18 care items selected either by clinicians or patients in Delphi round 2 (n=18).

The nominal group meeting started with an interactive activity in which the content and wording of the 18 candidate care items were reviewed. Multiple statements were condensed into one care item, where possible. In this process, 12 original items were compressed into five statements. These five abridged statements were reworded to make sure the meanings were unchanged. Two new care items that were not considered in Delphi rounds were added during the nominal group meeting: (1) screening for frailty and comorbid conditions, and (2) review goals of care. This process resulted in a final list of 13 COPD care items candidate for inclusion in the discharge bundle that were dot-counted during the nominal group meeting. Meeting participants voted on the 13 care items refined during the interactive activity. Each participant had a maximum of eight votes that she/he could use to select individual COPD care items for inclusion in the discharge care bundle. During an open discussion, meeting participants agreed on the cut-off mark for inclusion at 20 votes. The nominal group reached consensus on the inclusion of seven unique care items in the COPD discharge bundle ([figure 2](#F2){ref-type="fig"}): (1) ensure adequate inhaler technique is demonstrated; (2) send discharge summary to family physician and arrange follow-up; (3) optimise and reconcile prescription of respiratory medications; (4) provide a written discharge management plan and assess patients' and caregivers' comprehension of discharge instructions; (5) refer to pulmonary rehabilitation; (6) screen for frailty and comorbid conditions; and (7) assess smoking status, provide counselling and refer to smoking cessation programme.

![Results of the nominal group voting on the inclusion of individual care items in the chronic obstructive pulmonary disease (COPD) discharge bundle.](bmjresp-2017-000265f02){#F2}

Discussion {#s4}
==========

To our knowledge, this is the first reporting of a modified Delphi method to develop a COPD discharge care bundle informed by evidence, multidisciplinary clinical consensus and patients' perspectives. Using a mixed-methods approach we developed a seven-item patient-centred, evidence-based and consensus-based discharge bundle for patients with acute exacerbations of COPD.

There are important variations in the number and content of individual components of COPD discharge bundles published in scientific studies.[@R13] Our discharge bundle incorporated seven care items, a number that is aligned with recommendations about the optimal number of individual items for inclusion in care bundles.[@R11] Others have included between 2 and 12 individual interventions, with a median number of 5 care items per bundle.[@R13] Some care items in the COPD discharge bundle have been part of other published bundles. For example, care item \#1 was part of COPD discharge bundles in 9 out of 14 studies included in the Ospina *et al* systematic review.[@R13] Care items \#2, \#4 and \#5 were included in bundles of eight studies, and care item \#7 was included in seven studies evaluating other bundles. Care items \#3 (three studies) and \#6 (none) were less frequently included in other bundles. In contrast, educational programmes on self-management (included in nine studies) were not selected for the COPD discharge bundle.

This study is one of the few initiatives to inform the selection of individual components of COPD discharge bundles. The majority of studies in the field have not explained how individual care items were generated or selected for inclusion.[@R13] This lack of detail limits the ability of readers to understand how these bundles work, how they incorporate the best available evidence and whether individual components are accepted by patients and clinicians.

Care bundles were originally developed to improve adherence to clinical practice guidelines[@R28] and to decrease variations in care[@R29]; however, consistent uptake of recommendations from clinical practice guidelines into care bundles remains challenging.[@R28] For example, in North America, the American College of Chest Physicians (CHEST) and the CTS have developed recommendations about both pharmacological and non-pharmacological treatments to prevent acute exacerbations of COPD (the Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) Guidelines).[@R4] Not all AECOPD Guideline recommendations were translated into individual items in the COPD discharge bundle. Of 10 non-pharmacological recommendations in the AECOPD Guidelines,[@R4] 3 (ie, refer to pulmonary rehabilitation, having a written plan and case management for the prevention of acute exacerbations of COPD and smoking cessation counselling) were included in the COPD discharge bundle. Others (ie, administration of pneumococcal and influenza vaccines) were not included. One potential explanation for this lack of agreement is that the AECOPD Guidelines were based on a critical appraisal of the evidence supporting individual actions for preventing acute exacerbations of COPD,[@R4] whereas selection of care items in the COPD discharge bundle was based on evidence supporting bundles as a sum of individual components, plus clinician consensus and patients' perspectives on their relative importance. Alignment with clinical practice guidelines and feasibility of local adaptations of the COPD discharge bundle should be further explored to ensure wide applicability.

Strengths and limitations {#s4a}
-------------------------

The Delphi procedure is a valid method to determining consensus for clinical improvement practices in healthcare settings.[@R30] The number of experts (both clinicians and patients) who participated in both the Delphi and nominal group phases of the study surpassed the sample size recommended for content validation (ie, 5--10 experts)[@R31] of the COPD discharge care bundle. They represent multidisciplinary professional groups that directly influence patient care and the development of clinical practice guidelines. An important strength of this study was the participation of the CTS COPD Assembly and different types of clinicians, including primary care physicians who are instrumental in the integration of acute and chronic care of patients with COPD after discharge. This is key from a knowledge translation perspective. Also, incorporating the perspectives of patients with COPD is an important strength in the development of a patient-centred bundle that is more likely to lead to treatment adherence and better outcomes.[@R32] Lastly, the COPD care bundle represents a balance between pragmatism and completeness. The total number of items is not evidence-based, but the seven items identified in this study represent a consensus of what is possible, feasible and valid in practice.

This study has some limitations. Because clinician and patient samples were selected using non-random procedures (ie, purposeful and convenience sampling, respectively), representativeness, in a statistical sense, was not assured. Clinicians were predominantly experts from large, urban, academic hospitals, thereby limiting generalisation of results to rural, non-academic settings. The importance given to individual care items may vary according to local criteria and their availability in the settings from which the clinicians practice. Similarly, patients in the Delphi study may not fully represent those with very severe COPD that are more likely to have frequent admissions for acute exacerbations of COPD and require implementation of the discharge care bundle more often.

This Delphi study was conducted in Canada, a country with a publicly funded universal healthcare system. The selection of individual care items for a COPD discharge care bundle in countries with other health insurance models may differ as financial and insurance barriers often impede access to some individual COPD care items considered such as access to pulmonary rehabilitation services and appropriate inhaler medication. Therefore, generalisability of the COPD discharge bundle to other health systems may be limited. Local adaptations of the bundle should be evaluated prior to implementation in health systems supported by other financial and insurance arrangements. Adjustments in the content of COPD discharge bundles can be guided by consideration of system-level failures and unmet patient needs.[@R33]

An aspect that should be explored in future studies is whether individual components are perceived as more important for bundle effectiveness than the sum of all components. Some may argue that the strength of a COPD discharge bundle is that all individual interventions should be implemented in every eligible patient with COPD under a 'all-or-none' approach.[@R34] Others have questioned whether a 'one-size-fits-all' model is appropriate for discharge bundles that are meant to be implemented for the spectrum of patients with COPD and the diverse settings where they receive care.[@R19]

The work presented here is the second step of a multistage process aimed at evaluating the implementation and effectiveness of an evidence-based, patient-oriented discharge care bundle for patients with COPD. The first step was a systematic review of the scientific literature[@R13] that provided the evidence base for the discharge bundle development. Since the completion of the Delphi study, the research team engaged in the design and planning of a multicentre trial ([www.clinicaltrials.gov;](www.clinicaltrials.gov) study ID: NCT03358771) to evaluate the implementation and effectiveness of the COPD discharge bundle. Enrolment in the trial is expected to conclude in 2019, with the goal to obtain sufficient data for reliable estimates of the treatment effect for clinical decision-making.

Conclusions {#s5}
===========

This study proposes a patient-centred, evidence-based and consensus-based discharge care bundle for patients with acute exacerbations of COPD. The goal is that the discharge care bundle will ensure that patients with COPD are managed appropriately, effectively and in ways that are acceptable for them. This COPD discharge bundle provides a foundation for further research and critical evaluation of barriers and facilitators for implementation, implementation fidelity and effectiveness in healthcare settings.
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